medigraphic.com
ISSN 1405-8871 (Print)

2018, Number 3

<< Back Next >>

Aten Fam 2018; 25 (3)

Using the Gail Model to Identify Women at Hight Risk for Developing Breast Cancer

García GEZ, Alcalá MJA, Mendo RA

Language: Spanish
References: 19
Page: 114-117
PDF size: 147.66 Kb.


ABSTRACT

Objectives: To identify women at high risk of developing breast cancer (BC) based on the Gail model. Methods: analytical and cross-sectional study in 154 women from 35 to 64 years, who attended the Family Medicine external consultation from March to November 2016. They were questioned about risk factors for breast cancer and these were analyzed in the electronic Breast Cancer Risk Assessment Tool, based on the Gail model. A higher than or equal score to 1.66 represents a high risk of developing BC in the following five years. Results: 24 patients (16%) with high risk of bc development were identified. Women who referred first-grade family members with bc obtained higher scores. The identified women were referred to their family physician and, thanks to follow-up, the only bc diagnosed patient is currently in treatment. Conclusions: proportion of women at high risk for developing breast cancer in the following five years, measured by the Gail model, was elevated. It is proposed to incorporate the instrument in the primary care level, since the time of execution is brief and allows the identification and timely derivation of women with high suspicion of suffering the disease for the performance of confirmatory tests.


REFERENCES

  1. Secretaría de Salud. Estadísticas de cáncer de mama y cáncer cérvico uterino. Programa de acción específico prevención y control del cáncer de la mujer 2013-2018 [internet. Consultado el 15 noviembre de 2017]. Disponible en: https:// www.gob.mx/salud/acciones-y-programas/ informacion-estadistica

  2. Sistema Nacional de vigilancia Epidemiológica Sistema Único de información. México: numeralia de cáncer de mama. México: Secretaría de Salud; 2013. Boletín epidemiológico: 26.

  3. Chávez NH, Salamanca M. Epidemiología del cáncer de mama en hombres atendidos en el Centro Médico Nacional 20 de noviembre. Rev Esp Méd Quir. 2014;19(3):268.

  4. Shan R, Rosso K, Nathanson SD. Pathogenesis, prevention, diagnosis and treatment of breast cáncer. World J Clin Oncol. 2014;5(3):284-286.

  5. Quevedo KM, Landa AM, García V. her-2/neu en cáncer de mama localmente avanzado. Semergen. Elsevier. 2016;15(3):109-110.

  6. Vich P, Brusint B, Álvarez C, Cuadrado C, Díaz N, Redondo E, et al. Actualización del cáncer de mama en atención primaria. Semergen. Elsevier España. 2014;40(6):326-333.

  7. Calderón SA, Gallón LJ. Cáncer de mama asociado a mutaciones genéticas de los brca1 y 2. Rev CES Med. 2012;26(2):185-199.

  8. Fernandez A, Reigosa A. Cáncer de mama hereditario. Comunidad y Salud. Venezuela. 2016;14(1):52-60 [internet. Consultado el 15 noviembre de 2017]. Disponible en: http://www. redalyc.org/pdf/3757/375746275008.pdf

  9. Villarreal E, Escorcia V, Martínez L, Vargas ER, Galicia L, Cervantes R, et al. Historia natural del proceso diagnóstico del cáncer de mama. Rev Panam Salud Publica. 2014;35(3):172-8.

  10. Sifuentes A, Castañeda LY, Lugo M, Reyes MA. Factores de riesgo asociados con el cáncer de mama en mujeres del estado de Durango, México. Ginecol Obstet Mex. 2015;83:662-669.

  11. Maskarinec G, Morimoto Y, Laguaña MB, Novotny R, Leon RT. Bioimpedence to Assess Breast Density as a Risk Factor for Breast Cancer in Adult Women and Adolescent Girls. Asian Pac J Cancer Prev.2016;17(1),65-71.

  12. Mehrgou A, Akouchekian M. The importance of brca1 and brca2 genes mutations in breast cancer development. Med J Islam Repub Iran. 2016;30:369.

  13. Yang XR, Killian JK, Hammond S, Burke LS, Bennett H, Wang Y, et al. Characterization of Genomic Alterations in Radiation-Associated Breast Cancer among Childhood Cancer Survivors, Using Comparative Genomic Hybridization (cgh) Arrays. plos one.2015;10(3): 1-11.

  14. Li H, Sun X, Miller E, Wang Q, Tao Ping, Liu L, et al. bmi, reproductive factors, and breast cancer molecular subtypes: A case-control study and meta-analysis. Journal of Epidemiology. 2016;27:143-151.

  15. Neurhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, Obesity and Postmenopausal Invasive Breast Cancer Risk . JAMA Oncol. 2016;1(5):611-621.

  16. Rossil RE, Pericleous M, Mandair D, Whyand T, Caplin ME. The Role of Dietary Factors in Prevention and Progression of Breast Cancer. Anticancer Research. 2014;34:6861-6876.

  17. Land SR, Liu Q, Wickerham DL, Constantino JP, Ganz PA. Cigarette Smoking, Physical Activity, and Alcohol Consumption as Predictors of Cancer Incidence among Women at High Risk of Breast Cancer in the nsabp p-1 Trial. American Association for Cancer Research. 2014;23(5):823-832.

  18. Vich P, Brusint B, Álvarez C, Cuadrado C, Díaz N, Redondo E, et al. Actualización del cáncer de mama en atención primaria. Elsevier España. 2014;40(6):326-333.

  19. Aguilar MJ, Neri M, Padilla CA, Pimentel ML, García A, Sánchez AM. Factores de riesgo como pronóstico de padecer cáncer de mama en un estado de México. Nut Hosp. 2012;27(5):1631-1636. Modelo Gail y cáncer de mama Aten Fam. 2018;25(3):114-117. http://dx.doi.org/10.22201/facmed.14058871p.2018.3.65309




2020     |     www.medigraphic.com